Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety profile of immune checkpoint inhibitors according to cancer type.
Guérin C, Laramas M, Bettega F, Bocquet A, Berton E, Lugosi M, Bouillet L, Toffart AC. Guérin C, et al. Among authors: toffart ac. Bull Cancer. 2023 Jul-Aug;110(7-8):825-835. doi: 10.1016/j.bulcan.2023.04.011. Epub 2023 May 22. Bull Cancer. 2023. PMID: 37225616 Review.
Wegener granulomatosis revealed by pleural effusion.
Toffart AC, Arbib F, Lantuejoul S, Roux JF, Bland V, Ferretti G, Diab S. Toffart AC, et al. Case Rep Med. 2009;2009:164395. doi: 10.1155/2009/164395. Epub 2010 Feb 4. Case Rep Med. 2009. PMID: 20168982 Free PMC article.
Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma.
Domblides C, Leroy K, Monnet I, Mazières J, Barlesi F, Gounant V, Baldacci S, Mennecier B, Toffart AC, Audigier-Valette C, Doucet L, Giroux-Leprieur E, Guisier F, Ricordel C, Molinier O, Perol M, Pichon E, Robinet G, Templement-Grangerat D, Ruppert AM, Rabbe N, Antoine M, Wislez M. Domblides C, et al. Among authors: toffart ac. J Thorac Oncol. 2020 May;15(5):860-866. doi: 10.1016/j.jtho.2020.01.014. Epub 2020 Jan 25. J Thorac Oncol. 2020. PMID: 31991225 Free article.
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.
Gobbini E, Toffart AC, Pérol M, Assié JB, Duruisseaux M, Coupez D, Dubos C, Westeel V, Delaunay M, Guisier F, Veillon R, Gounant V, Giroux Leprieur E, Vanel FR, Chaabane N, Dansin E, Babey H, Decroisette C, Barlesi F, Daniel C, Fournel P, Mezquita L, Oulkhouir Y, Canellas A, Duchemann B, Molinier O, Alcazer V, Moro-Sibilot D, Levra MG. Gobbini E, et al. Among authors: toffart ac. Clin Lung Cancer. 2020 Sep;21(5):e497-e510. doi: 10.1016/j.cllc.2020.04.013. Epub 2020 May 8. Clin Lung Cancer. 2020. PMID: 32605892
Immune checkpoint inhibitors and hospitalization at home in France.
Gobbini E, Toffart AC, Boisserie Lacroix L, Pinsolle J, Schoutteten L, Federspiel I, Pierret T, Pérol M, Feyeux A. Gobbini E, et al. Among authors: toffart ac. Bull Cancer. 2022 Jan;109(1):89-97. doi: 10.1016/j.bulcan.2021.09.012. Epub 2021 Nov 14. Bull Cancer. 2022. PMID: 34785029
When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study.
Meert AP, Toffart AC, Picard M, Jaubert P, Gibelin A, Bauer P, Mokart D, Van De Louw A, Hatzl S, Moreno-Gonzales G, Rousseau-Bussac G, Bruneel F, Montini L, Moreau AS, Carpentier D, Seguin A, Hemelaar P, Azoulay E, Lemiale V. Meert AP, et al. Among authors: toffart ac. Bull Cancer. 2022 Sep;109(9):916-924. doi: 10.1016/j.bulcan.2022.04.014. Epub 2022 Jun 16. Bull Cancer. 2022. PMID: 35718570
90 results